The interaction of co-occurring mental disorders and recovery management checkups on substance abuse treatment participation and recovery

Evaluation Review
Brian RushRodney Funk

Abstract

This article examines the effectiveness of quarterly Recovery Management Checkups (RMCs) for people with substance disorders by level of co-occurring mental disorders (34% none, 27% internalizing disorders, and 39% internalizing and externalizing) across two randomized experiments with 92% to 97% follow-up. The 865 participants are 82% African American, 53% female, and age 37 on average. RMC involves identification of those in need of treatment, motivational interviews, and treatment linkage assistance. It is effective in linking participants in need to treatment, with equal or better outcomes among those with more mental disorders. The data support the utility of monitoring and re-intervention for clients with co-occurring disorders.

Associated Clinical Trials

References

Jan 1, 1990·Journal of Substance Abuse Treatment·M HansonW Gross
Apr 1, 1989·Journal of Psychoactive Drugs·B E StoffelmayrB E Mavis
Nov 1, 1988·Archives of General Psychiatry·H E RossT Germanson
Aug 1, 1986·Archives of General Psychiatry·B J RounsavilleH D Kleber
Jun 1, 1983·Archives of General Psychiatry·A T McLellanK A Druley
Dec 1, 1994·Alcoholism, Clinical and Experimental Research·E C PenickJ Campbell
Sep 1, 1993·The Journal of Nervous and Mental Disease·A I AltermanR B Shifman
Oct 1, 1995·Alcoholism, Clinical and Experimental Research·C E LewisE Spitznagel
Jan 1, 1996·The American Journal of Orthopsychiatry·R E DrakeM A Wallach
Aug 1, 1997·Psychiatric Services : a Journal of the American Psychiatric Association·D HienS Ackerman
Jan 23, 1998·Journal of Substance Abuse Treatment·Y I HserM L Prendergast
Sep 30, 1998·Recent Developments in Alcoholism : an Official Publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism·R E Drake, M F Brunette
Nov 5, 1998·Addictive Behaviors·M KrauszU Verthein
Sep 3, 1999·The American Journal of Drug and Alcohol Abuse·C E Grella, V Joshi
Oct 26, 1999·Archives of General Psychiatry·R F Krueger
Oct 4, 2000·JAMA : the Journal of the American Medical Association·A T McLellanH D Kleber
Feb 7, 2001·The British Journal of Psychiatry : the Journal of Mental Science·G AndrewsW Hall
Feb 13, 2001·Drug and Alcohol Dependence·J S CacciolaF D Mulvaney
Feb 13, 2001·Journal of Substance Abuse Treatment·R J GlassD Rentz
May 18, 2001·Social Psychiatry and Psychiatric Epidemiology·I Schaar, A Ojehagen
Jun 29, 2001·Archives of General Psychiatry·W A VolleberghJ Ormel
Aug 21, 2001·Journal of Affective Disorders·W McDermutM Zimmerman
May 9, 2002·Social Psychiatry and Psychiatric Epidemiology·L BatstraJ Neeleman
Jun 4, 2002·Journal of Abnormal Child Psychology·Shari Miller-JohnsonUNKNOWN Conduct Problems Prevention Research Group
Sep 21, 2002·European Archives of Psychiatry and Clinical Neuroscience·Jules AngstKathleen Ries Merikangas
Nov 1, 2002·Journal of the American Academy of Child and Adolescent Psychiatry·Jeffrey D BurkeBoris Birmaher
Dec 4, 2002·Addiction·Michael DennisUNKNOWN C. Y. T. Steering Committee
May 3, 2003·The American Journal of Psychiatry·Wilson M ComptonEdward L Spitznagel
Nov 5, 2003·The British Journal of Psychiatry : the Journal of Mental Science·Robin E Clark, Kim T Mueser
Jun 30, 2004·Psychiatric Rehabilitation Journal·Robert E DrakeGregory J McHugo

❮ Previous
Next ❯

Citations

Mar 20, 2013·Journal of Substance Abuse Treatment·Alexandre B Laudet, Keith Humphreys
Feb 5, 2010·Journal of Substance Abuse Treatment·Sherry LipskyAlice Huber
May 14, 2014·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·José J López-GoñiAlfonso Arteaga
Dec 18, 2008·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Brian Rush, Christopher J Koegl
Jun 28, 2019·Substance Abuse Treatment, Prevention, and Policy·Kristen A MorinDavid C Marsh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.